NEUROONE MEDICAL TECHNOLOGIE (NMTC) Institutional Shareholders
NEUROONE MEDICAL TECHNOLOGIE (NMTC) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $7.69M in NMTC holdings during the latest filing period.
Bleichroeder Lp is currently the largest disclosed institutional shareholder of NMTC tracked by InsiderSet, reporting ownership valued at approximately $3.11M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $6.76M, representing an estimated gain of +117.64% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 98% of the total disclosed NMTC value among the investors covered in this analysis. Major shareholders include Bleichroeder Lp, Bard Associates Inc, Vanguard Capital Management Llc, and several other long-term asset managers with concentrated positions in NEUROONE MEDICAL TECHNOLOGIE (NMTC).
This page ranks the largest institutional NMTC shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
24
Total Reported Value
$7.69M
Largest Holder
Bleichroeder Lp
Largest Position
$3.11M
Insider Transactions (90d)
1
Latest Filing Quarter
Q2 2026
New Institutional Positions
42
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Bleichroeder Lp | 0.54% | 4,000,000 | $3,106,000 | $6,760,000 | +$3,654,000 | +117.64% | |
| Bard Associates Inc | 0.36% | 1,840,498 | $1,429,147 | $3,110,442 | +$1,681,295 | +117.64% | |
| Vanguard Capital Management Llc | 0.00% | 1,397,329 | $1,085,725 | $2,361,486 | +$1,275,761 | +117.50% | |
| Renaissance Technologies LLC | Jim Simons | 0.00% | 655,446 | $508,954 | $1,107,704 | +$598,750 | +117.64% |
| Geode Capital Management, Llc | 0.00% | 615,606 | $478,075 | $1,040,374 | +$562,299 | +117.62% | |
| Sio Capital Management, Llc | 0.06% | 496,614 | $385,621 | $839,278 | +$453,657 | +117.64% | |
| Vanguard Fiduciary Trust Co | 0.00% | 292,081 | $226,947 | $493,617 | +$266,670 | +117.50% | |
| Essex Investment Management Co Llc | 0.03% | 261,953 | $203,407 | $442,701 | +$239,294 | +117.64% | |
| Northern Trust Corp | 0.00% | 112,123 | $87,064 | $189,488 | +$102,424 | +117.64% | |
| State Street Corp | 0.00% | 59,499 | $46,201 | $100,553 | +$54,352 | +117.64% | |
| Xtx Topco Ltd | 0.00% | 43,283 | $33,609 | $73,148 | +$39,539 | +117.64% | |
| Two Sigma Securities, Llc | 0.00% | 24,764 | $19,229 | $41,851 | +$22,622 | +117.65% | |
| United Community Bank | 0.01% | 20,000 | $15,530 | $33,800 | +$18,270 | +117.64% | |
| Arch Global Advisors, Llc | 0.01% | 17,434 | $13,538 | $29,463 | +$15,925 | +117.64% | |
| Lpl Financial Llc | 0.00% | 15,034 | $11,674 | $25,407 | +$13,733 | +117.64% | |
| Morgan Stanley | 0.00% | 12,096 | $9,393 | $20,442 | +$11,049 | +117.63% | |
| Princeton Global Asset Management Llc | 0.00% | 2,805 | $8,527 | $4,740 | -$3,787 | -44.41% | |
| Aqr Capital Management Llc | 0.00% | 10,420 | $8,091 | $17,610 | +$9,519 | +117.65% | |
| Mariner, Llc | 0.00% | 10,420 | $8,091 | $17,610 | +$9,519 | +117.65% | |
| Wells Fargo & Company/Mn | 0.00% | 1,000 | $777 | $1,690 | +$913 | +117.50% | |
| Citigroup Inc | 0.00% | 975 | $757 | $1,648 | +$891 | +117.67% | |
| Osaic Holdings, Inc. | 0.00% | 350 | $273 | $592 | +$319 | +116.67% | |
| Ubs Group Ag | 0.00% | 108 | $84 | $183 | +$99 | +117.29% | |
| Quent Capital, Llc | 0.00% | 40 | $31 | $68 | +$37 | +118.06% |
Frequently asked questions about NMTC
Who owns the most NMTC stock?
The largest holders of NMTC are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for NEUROONE MEDICAL TECHNOLOGIE (NMTC).
Is NMTC widely held by superinvestors?
Many widely followed stocks like NMTC appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly NMTC is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.